EIF2B2 mutations in vanishing white matter disease hypersuppress translation and delay recovery during the integrated stress response

RNA
Stephanie L Moon, Roy Parker

Abstract

Mutations in eIF2B genes cause vanishing white matter disease (VWMD), a fatal leukodystrophy that can manifest following physical trauma or illness, conditions that activate the integrated stress response (ISR). EIF2B is the guanine exchange factor for eIF2, facilitating ternary complex formation and translation initiation. During the ISR, eIF2α is phosphorylated and inhibits eIF2B, causing global translation suppression and stress-induced gene translation, allowing stress adaptation and recovery. We demonstrate that VWMD patient cells hypersuppress translation during the ISR caused by acute ER stress, delaying stress-induced gene expression and interrupting a negative feedback loop that allows translational recovery by GADD34-mediated dephosphorylation of phospho-eIF2α. Thus, cells from VWMD patients undergo a prolonged state of translational hyperrepression and fail to recover from stress. We demonstrate that small molecules targeting eIF2B or the eIF2α kinase PERK rescue translation defects in patient cells. Therefore, defects in the ISR could contribute to white matter loss in VWMD.

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·O ThastrupA P Dawson
Jan 1, 1995·Journal of Bioluminescence and Chemiluminescence·R D PettyI A Cree
Jul 1, 1996·Neurobiology of Aging·K L DoubleG A Broe
Apr 23, 2003·American Journal of Human Genetics·Anne FogliOdile Boespflug-Tanguy
Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eiji KojimaKen-ichi Isobe
Sep 6, 2005·Journal of Neuropathology and Experimental Neurology·J Patrick van der VoornMarjo S van der Knaap
Sep 28, 2005·Neurobiology of Disease·Barbara van KollenburgGert C Scheper
Jul 11, 2006·Journal of Neuropathology and Experimental Neurology·Barbara van KollenburgMarjo S van der Knaap
Jun 15, 2007·Archives of Neurology·Valerie A CardenasColin Studholme
Dec 16, 2010·Journal of Neuropathology and Experimental Neurology·Marianna BugianiMarjo S van der Knaap
Jan 8, 2013·Molecular Cell·Reut ShalgiChristopher B Burge
Jul 16, 2013·Biochimica Et Biophysica Acta·Renata Sano, John C Reed
Mar 7, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gulnaz BegumDandan Sun
May 24, 2014·Nature Communications·Yuliya GordiyenkoCarol V Robinson
Sep 5, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yifeng LinWensheng Lin
Jul 15, 2015·Journal of Neuropathology and Experimental Neurology·Julius BruchGünter U Höglinger
Nov 29, 2015·Biochemical Society Transactions·Noel C Wortham, Christopher G Proud
Feb 24, 2016·Nature·Kazuhiro KashiwagiShigeyuki Yokoyama
Sep 16, 2016·EMBO Reports·Karolina Pakos-ZebruckaAdrienne M Gorman
Jul 12, 2017·Proceedings of the National Academy of Sciences of the United States of America·Austin ChouSusanna Rosi
Dec 9, 2017·Molecular Cell·Bo-Jhih GuanMaria Hatzoglou

❮ Previous
Next ❯

Citations

May 3, 2019·The Journal of Neuropsychiatry and Clinical Neurosciences·Andrea AccogliRoberta La Piana
Aug 18, 2018·Scientific Reports·Stephanie L Moon, Roy Parker
Sep 22, 2020·Wiley Interdisciplinary Reviews. RNA·Geena Skariah, Peter K Todd
Feb 20, 2020·JIMD Reports·Carolyn BursleJoy Yaplito-Lee
Sep 1, 2021·Glia·Savannah G SimsGordon P Meares
Sep 1, 2021·Wiley Interdisciplinary Reviews. RNA·Alyssa M EnglishStephanie L Moon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.